Related Experiment Video
Updated: Oct 15, 2025
09:12
Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
1.1K
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy
Priyamvada Jayaprakash1, Paolo Dario Angelo Vignali2, Greg M Delgoffe2
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA;
Annual Review of Medicine
|October 26, 2021
Summary
Reducing cancer hypoxia can enhance anti-tumor immunity and immunotherapy effectiveness. Clinical trials combining hypoxia reduction with immune checkpoint blockade show promise for advanced cancers.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Cancers require increased oxygen and nutrients for expansion, leading to abnormal vasculature.
- Tumor hypoxia arises from irregular blood vessels and increased cellular oxygen consumption.
- Hypoxia and nutrient deprivation suppress anti-tumor immunity and promote tumor growth.
Purpose of the Study:
- To investigate the potential of reversing cancer hypoxia.
- To evaluate the impact of hypoxia reversal on anti-tumor immunity and immunotherapy response.
Main Methods:
- The study discusses the biological consequences of tumor hypoxia.
- It reviews early clinical trials combining hypoxia reduction strategies with immune checkpoint blockade.
Main Results:
- Reversing cancer hypoxia can improve T cell survival and function.
- Hypoxia reversal may resensitize tumors to immunotherapy.
- Early clinical trials show promising results in advanced, metastatic cancers.
Conclusions:
- Targeting tumor hypoxia is a promising strategy to enhance anti-tumor immunity.
- Combining hypoxia reduction with immune checkpoint inhibitors offers therapeutic potential for refractory cancers.
Related Concept Videos
02:49Cancer Therapies
8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
02:53Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
01:27Tumor Immunotherapy
736
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
736
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:50Combination Therapies and Personalized Medicine
5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K